Patents by Inventor Jeff Duyn

Jeff Duyn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9545217
    Abstract: Provided are methods and systems for movement correction in an MRI environment. In one aspect, provided are systems and methods for movement correction, comprising receiving a first plurality of images from a first scan of a subject with a first camera, receiving magnetic resonance imaging (MRI) images obtained concurrently with the first scan, correlating the first plurality of images obtained from the first scan with the MRI images, resulting in motion correction data, and providing the motion correction data to an MRI system, wherein the MRI system adjusts scanning according to the motion correction data.
    Type: Grant
    Filed: April 17, 2009
    Date of Patent: January 17, 2017
    Assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services
    Inventors: Jeff Duyn, Lei Qin
  • Publication number: 20110201916
    Abstract: Provided are methods and systems for movement correction in an MRI environment. In one aspect, provided are systems and methods for movement correction, comprising receiving a first plurality of images from a first scan of a subject with a first camera, receiving magnetic resonance imaging (MRI) images obtained concurrently with the first scan, correlating the first plurality of images obtained from the first scan with the MRI images, resulting in motion correction data, and providing the motion correction data to an MRI system, wherein the MRI system adjusts scanning according to the motion correction data.
    Type: Application
    Filed: April 17, 2009
    Publication date: August 18, 2011
    Inventors: Jeff Duyn, Lei Qin
  • Patent number: 5685305
    Abstract: A magnetic resonance imaging system and method for detecting blood flow abnormalities according to the time delay for the arrival of a bolus of a MR contrast agent into localized regions as observed in a temporal series magnetic resonance signals or images obtained subsequent to bolus injection. A rapid series of imaging pulse sequences acquires the time development of the signal from localized regions within the imaged field of view of a body. During the imaging period, a bolus of a MR contrast agent is injected into the cardiovascular system of the body. As the MR contrast material circulates through the imaged region, the associated field gradient which extends into the surrounding tissue results in signal losses in the acquired signal from these regions. The arrival time for the bolus into a given localized region is determined from the acquired time data, and the relative arrival time among regions in the imaged field of view indicates whether there is decreased blood flow to certain areas.
    Type: Grant
    Filed: August 5, 1994
    Date of Patent: November 11, 1997
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Chrit T. W. Moonen, Jeff Duyn, Peter van Gelderen
  • Patent number: 5570019
    Abstract: A nuclear magnetic resonance pulse sequence to provide spectral encoding so that the resulting series of spin-echoes each include both spatial and spectral information for spectroscopic imaging. Atoms within the object are excited and may then be spatially encoded, as by a phase encoding gradient. A series of refocusing pulses is then applied, inducing a respective series of spin-echoes. Spectral information is directly encoded in the spin-echo signals. The multiple spin-echoes may be used for sampling different points of k-space, and/or for increasing the signal-to-noise ratio by averaging. In an alternative embodiment, the present invention produces compound weighted spectroscopic images by selecting the period between refocussing pulses according to the coupling constant of a group contained in the compound; thereby, the signal of the selected compounds modulate with a known frequency different for compounds with different coupling constants.
    Type: Grant
    Filed: October 3, 1995
    Date of Patent: October 29, 1996
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Chrit T. W. Moonen, Jeff Duyn